Cetuximab attachment resulted in a nanosystem capable of specific delivery of drugs to epidermal growth factor receptor (EGFR)-hyperexpressing cancer cells in epidermoid carcinoma [65]. Here, EGFR is linked to squamous cell carcinoma.